Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: Involvement of caspase-3

GLIA

Volumn 38, Issue 3, 2002, Pages 228-239

  Hostettler, Mary Ellen ^a   Knapp, Pamela E ^a   Carlson, Sonia L ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; BN 52021; Caspases; Cell culture; Glia; Knockout; PAF; Spinal cord injury; WEB 2170

Indexed keywords

ANTITHROMBOCYTIC AGENT; AZEPINE DERIVATIVE; BEPAFANT; CASP3 PROTEIN, MOUSE; CASPASE; CASPASE 3; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; DITERPENE; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GINKGOLIDE; GINKGOLIDE B; GLIAL FIBRILLARY ACIDIC PROTEIN; LACTONE; OLIGODENDROCYTE O ANTIGEN, MOUSE; SCAVENGER; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TRIAZOLE DERIVATIVE;

ANIMAL; ARTICLE; ASTROCYTE; CBA MOUSE; CELL CULTURE; CELL DEATH; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; INFLAMMATION; METABOLISM; MOUSE; NEWBORN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD INJURY;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, DIFFERENTIATION; ASTROCYTES; AZEPINES; CASPASE 3; CASPASES; CELL DEATH; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; GINKGOLIDES; GLIAL FIBRILLARY ACIDIC PROTEIN; INFLAMMATION; LACTONES; MICE; MICE, INBRED CBA; OLIGODENDROGLIA; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SPINAL CORD INJURIES; TRIAZOLES;

EID: 0036562620     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10065     Document Type: Article

References (64)

1. Platelet-activating factor in the modulation of excitatory amino acid neurotransmitter release and of gene expression
2. Platelet-activating factor is both a modulator of synaptic function and a mediator of cerebral injury and inflammation
3. Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: Intracellular PAF-binding sites and activation of a fos/jun/AP-1 transcriptional signaling system
4. Mediators of injury in neurotrauma: Intracellular signal transduction and gene expression
5. Review of current evidence for apoptosis after spinal cord injury
6. Platelet activating factor receptor expression is associated with neuronal apoptosis in an in vivo model of excitotoxicity
7. Platelet-activating factor modulates interleukin-6 production by mouse fibroblasts
8. Perspectives in platelet-activating factor research
9. Functional PAF receptors in glia cells: Binding parameters and regulation of expression
10. Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis
11. Acute inflammatory response in spinal cord following impact injury
12. Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonists
13. Caspase and calpain substrates: Roles in synaptic plasticity and cell death
14. Extracellular calcium deprivation in astrocytes: Regulation of mRNA expression and apoptosis
15. Misoprostol therapeutics revisited
16. Apoptosis after traumatic human spinal cord injury
17. HIV-1-induced neuronal injury in the developing brain
18. Platelet-activating factor reduces spinal cord blood flow and causes behavioral deficits after intrathecal administration in rats through a specific receptor mechanism
19. Differential c-Fos and caspase expression following kainic acid excitotoxicity
20. Platelet-activating factor. A putative mediator in central nervous system injury?
21. Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons
22. Platelet-activating factor - Key mediator in neuroinjury?
23. Platelet-activating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin
24. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1
25. PAF antagonist treatment reduces pro-inflammatory cytokine mRNA after spinal cord injury
26. Increase of oligodendrocyte progenitor cells after spinal cord injury
27. Activation of immediate early gene, c-fos, and c-jun in the rat small intestine after ischemia/reperfusion
28. Mitochondrial membrane permeabilization during the apoptotic process
29. Injury stimulates outgrowth and motility of oligodendrocytes grown in vitro
30. Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor
31. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
32. Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury
33. Apoptosis and expression of Bcl-2 after compression trauma to rat spinal cord
34. Apoptosis of oligodendrocytes occurs for long distances away from the primary injury after compression trauma to rat spinal cord
35. Platelet-activating factor in stroke and brain injury
36. Antagonism of neutrophil adherence in the deteriorating stroke model in rabbits
37. Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits
38. Platelet-activating factor in the CNS
39. Platelet-activating factor is a messenger in the electroconvulsive shock-induced transcriptional activation of c-fos and zif-268 in hippocampus
40. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex
41. Hydrolysis of polyphosphoinositides in astrocytes by platelet-activating factor
42. Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury
43. Arachidonic acid cyclooxygenase and lipoxygenase pathways are differently activated by platelet activating factor and the caicium-ionophore A23187 in a primary culture of astroglial cells
44. Eicosanoid and inositol phosphate response to platelet-activating factor (PAF) and to a PAF antagonist in rat astroglial cells
45. Decreased apoptosis in proliferative and postmitotic regions of the Caspase 3-deficient embryonic central nervous system
46. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats
47. Emerging roles of caspase-3 in apoptosis
48. Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells
49. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor
50. CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: A key role in brain inflammation?
51. Implications of p53 protein expression in experimental spinal cord injury
52. Platelet-activating factor is a general membrane perturbant
53. Caspases determine the vulnerability of oligodendrocytes in the ischemic brain
54. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats
55. Recent developments in drug therapy for multiple sclerosis
56. Cells that are O4 antigen-positive and O1 antigen-negative differentiate into O1 antigen-positive oligodendrocytes
57. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury
58. DNA damage and activated caspase-3 expression in neurons and astrocytes: Evidence for apoptosis in frontotemporal dementia
59. 2+ reperfusion injury of cultured astrocytes: Roles of reactive oxygen species and NF-kappaB activation
60. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms
61. Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor
62. c-fos controls the "private pathway" of light-induced apoptosis of retinal photoreceptors
63. In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes
64. Apoptosis in cellular compartments of rat spinal cord after severe contusion injury